Company profile
InnerScope Hearing Technologies, Inc.
OTC: INND · Healthcare · Medical - Instruments & Supplies
#1021 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ 15GM —SS 29
v0.1 · 25/100 weight · pillars only
↑ Piotroski F, Altman-Z · ↓ market scale, filing timeliness
Methodology →Revenue TTM
$60.7k
Rev growth YoY (TTM)
-34.5%
Net income (FY)
-$5.0M
Employees
26
as of 2026-07-12
Market cap
$306
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$166.1k$166.1k2020
Net income-$5.0M-$5.0M2020
Operating income-$1.2M-$1.2M2020
Total assets$1.7M$1.7M2020
Liabilities$12.0M$12.0M2020
Equity-$10.4M-$10.4M2020
Revenue trend
FY2016 – FY2020 · USD
FY16
FY16
FY17
FY18
FY20
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is InnerScope Hearing Technologies, Inc.’s revenue?
InnerScope Hearing Technologies, Inc. booked $166.1k in FY2020 revenue, contracting 80% year over year — slower than 88% of Healthcare companies we track, at a -2982.2% net margin.
Peers · Healthcare
MedMira Inc.31DEden Empire Inc.——Lisata Therapeutics, Inc.39DKalaris Therapeutics Inc30DCurative Biosciences, Inc.——ZIVO Bioscience, Inc.——Key facts
CEOMatthew Ross Moore
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersRoseville, CA
ExchangeOTC: INND
Employees26
IPO date2017-03-15
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.